These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30902795)

  • 21. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth.
    Zhou T; Sang YH; Cai S; Xu C; Shi MH
    Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication.
    Luo M; Luo Y; Mao N; Huang G; Teng C; Wang H; Wu J; Liao X; Yang J
    Cell Physiol Biochem; 2018; 51(1):315-336. PubMed ID: 30453281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity.
    Rodrigues-Silva E; Siqueira-Santos ES; Ruas JS; Ignarro RS; Figueira TR; Rogério F; Castilho RF
    J Neurooncol; 2017 Jul; 133(3):519-529. PubMed ID: 28540666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
    Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage.
    Deng H; Gao Y; Trappetti V; Hertig D; Karatkevich D; Losmanova T; Urzi C; Ge H; Geest GA; Bruggmann R; Djonov V; Nuoffer JM; Vermathen P; Zamboni N; Riether C; Ochsenbein A; Peng RW; Kocher GJ; Schmid RA; Dorn P; Marti TM
    Cell Mol Life Sci; 2022 Jul; 79(8):445. PubMed ID: 35877003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress.
    Ronca R; Ghedini GC; Maccarinelli F; Sacco A; Locatelli SL; Foglio E; Taranto S; Grillo E; Matarazzo S; Castelli R; Paganini G; Desantis V; Cattane N; Cattaneo A; Mor M; Carlo-Stella C; Belotti A; Roccaro AM; Presta M; Giacomini A
    Cancer Res; 2020 Jun; 80(11):2340-2354. PubMed ID: 32094301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.
    Wang Q; Gao G; Zhang T; Yao K; Chen H; Park MH; Yamamoto H; Wang K; Ma W; Malakhova M; Bode AM; Dong Z
    Cancer Res; 2018 Jul; 78(14):3982-3994. PubMed ID: 29748372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: Mitochondrial proton leak and inhibition of the electron transport system.
    Hall A; Larsen AK; Parhamifar L; Meyle KD; Wu LP; Moghimi SM
    Biochim Biophys Acta; 2013 Oct; 1827(10):1213-25. PubMed ID: 23850549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
    Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
    Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIF-regulated oxidative phosphorylation supports lung cancer development.
    Rao S; Mondragón L; Pranjic B; Hanada T; Stoll G; Köcher T; Zhang P; Jais A; Lercher A; Bergthaler A; Schramek D; Haigh K; Sica V; Leduc M; Modjtahedi N; Pai TP; Onji M; Uribesalgo I; Hanada R; Kozieradzki I; Koglgruber R; Cronin SJ; She Z; Quehenberger F; Popper H; Kenner L; Haigh JJ; Kepp O; Rak M; Cai K; Kroemer G; Penninger JM
    Cell Res; 2019 Jul; 29(7):579-591. PubMed ID: 31133695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NALP3 orchestrates cellular bioenergetics to facilitate non-small cell lung cancer cell growth.
    He ZF; Jin XR; Lin JJ; Zhang X; Liu Y; Xu HL; Xie DY
    Life Sci; 2020 Jan; 241():117165. PubMed ID: 31838136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
    Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
    Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
    Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
    Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
    Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
    Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minerval (2-hydroxyoleic acid) causes cancer cell selective toxicity by uncoupling oxidative phosphorylation and compromising bioenergetic compensation capacity.
    Massalha W; Markovits M; Pichinuk E; Feinstein-Rotkopf Y; Tarshish M; Mishra K; Llado V; Weil M; Escriba PV; Kakhlon O
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30602451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.